DS
GILD icon

DRW Securities’s Gilead Sciences GILD Stock Holding History

DRW Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,400
Closed -$321K – 284
2022
Q1 		$321K Buy
+5,400
New +$345K 0.01% 199

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

DRW Securities's GILD Position: Q1 2026 in Review

DRW Securities reduced its Gilead Sciences (GILD) stake by 20% in Q1 2026, selling an estimated $114K and leaving 3,207 shares worth $438K. The position accounts for 0.01% of the portfolio, ranked #673.

DRW Securities first reported a position in GILD in Q3 2013 and has held it in 17 quarters since. The position peaked at $6.13M in Q4 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • DRW Securities held 3,207 shares of Gilead Sciences worth $438K as of Q1 2026.
  • DRW Securities sold 817 Gilead Sciences shares in Q1 2026, an estimated $114K.
  • Gilead Sciences made up 0.01% of DRW Securities's portfolio in Q1 2026, its #673 holding.
  • DRW Securities first reported a position in Gilead Sciences in Q3 2013 and has held it in 17 quarters since.
  • DRW Securities's Gilead Sciences position peaked at $6.13M in Q4 2014.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.